With chronic kidney disease (CKD) cases steadily rising across India, particularly in semi-urban and rural areas, the need for affordable and advanced dialysis treatment is more urgent than ever. Against this backdrop, the dialysis machines market in India is projected to grow at a 2 per cent compound annual growth rate (CAGR) during 2025-36, according to GlobalData.
GlobalData’s report, “Dialysis Machines Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that India’s dialysis machines market accounted for around 3 per cent of the Asia-Pacific market in 2024. This highlights the significant potential for further expansion driven by a rising disease burden and improving healthcare infrastructure.
Renalyx Health Systems has recently launched Renalyx RxT21, which is claimed to be India’s first fully indigenous, AI and cloud-enabled smart dialysis machine featuring real-time remote monitoring and clinical connectivity. By reducing manual intervention and streamlining clinical workflows, RxT21 is designed to promote patient safety, help lower the risk of complications and contribute to more efficient treatment outcomes.
Nidhi Bharti, Medical Devices Analyst, GlobalData, comments, “Access to effective dialysis in India is often limited by high costs, insufficient infrastructure, and the need for continuous patient monitoring to prevent complications. The emergence of AI-driven and cloud-connected technologies is enabling earlier interventions and personalised care, especially in resource-scarce regions. Such advancements hold the promise of improving treatment outcomes and expanding the availability of quality renal care to a wider segment of the population.”
Smart dialysis technologies are transitioning beyond traditional hospital settings. By integrating telehealth and real-time remote monitoring, these innovations facilitate timely clinical actions and enhance resource management. This is crucial for improving healthcare delivery in both urban centres and underserved areas.
Bharti concludes, “The integration of AI and cloud technology into dialysis represents a significant transformation in the management of renal disease. Such in-house advancements serve to reduce costs and enhance the quality of care while also aligning with the government’s ‘Make in India, Make for the World’ initiative, making advanced care accessible to patients across the globe.”
